

(Alliance News) - IP Group PLC on Tuesday announced that portfolio company Istesso has commenced dosing for the IST-03 trial of leramistat in sarcopen...


(Sharecast News) - Science and technology investment firm IP Group said on Tuesday that portfolio company Istesso has begun dosing patients in a Phase...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued from April 20 to April 24 and not sep...


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:


(Alliance News) - Kenmare Resources PLC on Wednesday reported a 20% drop in annual mineral product revenue, but said it is on track to achieve its gui...


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.